AB032. 174. Contemporary review of bypass surgery in the endovascular era
Vascular/Radiology Session

AB032. 174. Contemporary review of bypass surgery in the endovascular era

Ciara Ryan1,2, Wael Tawfick1,2, Mohamed ElSherif2, Mark Curtin2, Niamh Hynes3, Sherif Sultan1,2,3

1School of Medicine, National University of Ireland, Galway, Ireland; 2Western Vascular Institute, University College Hospital, Galway, Ireland; 3Galway Clinic, Royal College of Surgeons of Ireland, Galway, Ireland


Background: Despite the popularity of endovascular revascularisation, bypass procedures still play an important role in critical limb ischaemia (CLI) management. The study aims to compare outcomes of synthetic versus natural conduits. Primary endpoint is amputation-free survival. Secondary endpoints include clinical success, haemodynamic success, patency rates and overall survival.

Methods: Clinical details of patients undergoing lower limb bypass from 2008 to 2016 were reviewed. Outcomes of autologous vein bypass grafts were compared to those of synthetic conduits.

Results: Over 8 years, 623 patients were referred with CLI. 105 underwent bypass procedures. All procedures were performed for TASC C/D lesions. Sixty-four bypasses were performed using a synthetic conduit and 41 using autologous vein. About 95.9% of synthetic bypasses were above the knee and 91.9% of veins were below the knee. Demographics, vascular-related risk factors, lesion length and runoff grading were comparable in both groups. Postoperative major adverse cardiovascular events and major adverse limb events were similar in both groups. Immediate clinical improvement to Rutherford Category ≤3 was 89.7% in synthetic bypasses vs. 70.3% in autologous veins (P=0.016). Hemodynamic success with ABI’s improving by ≥0.10 occurred in 87.3% of synthetic bypasses vs. 87.1% in vein bypasses (P=1). At 5 years, primary, assisted primary and secondary patency were 54.2%, 66.3%, 68.4% respectively. Amputation-free survival was 89.8% with synthetic grafts and 92.7% with veins (P=0.472). Overall survival was 62% for synthetic graft patients versus 65.9% with vein graft (P=0.406).

Conclusions: In patients where autologous veins are unavailable, synthetic bypass grafts still provide acceptable clinical outcomes, with comparable patency and amputation rates.

Keywords: Bypass; autologous; synthetic


doi: 10.21037/map.2018.AB032


Cite this abstract as: Ryan C, Tawfick W, ElSherif M, Curtin M, Hynes N, Sultan S. Contemporary review of bypass surgery in the endovascular era. Mesentery Peritoneum 2018;2:AB032. doi: 10.21037/map.2018.AB032